Shares in Protherics Plc (PTI.L: Quote, Profile, Research) hit their highest level in nearly six years on Thursday as the British biotech company said it stood to gain from U.S. use of its technology in a mad cow disease test.
Shares in Protherics Plc (PTI.L: Quote, Profile, Research) hit their highest level in nearly six years on Thursday as the British biotech company said it stood to gain from U.S. use of its technology in a mad cow disease test.
